- Home
- Labeler Index
- Patheon Pharmaceuticals Inc.
- 67651-0223
- NDC Crossover: 67651-0223 Linagliptin And Metformin Hydrochloride
NDC Crossover 67651-0223 Linagliptin And Metformin Hydrochloride
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Linagliptin; Metformin Hydrochloride
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 67651-0223 – Linagliptin And Metformin Hydrochloride, drug for further processing. This list includes other cross-matching products that share:
- The same product name: Linagliptin And Metformin Hydrochloride
- OR Generic name: Linagliptin And Metformin Hydrochloride
- AND the same Administration Route:
- OR Dosage Form: tablet, film coated, extended release
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 0597-0270 | Jentadueto Xr | Linagliptin And Metformin Hydrochloride | Tablet, Film Coated, Extended Release | Oral | Boehringer Ingelheim Pharmaceuticals, Inc. | Human Prescription Drug |
| 0597-0275 | Jentadueto Xr | Linagliptin And Metformin Hydrochloride | Tablet, Film Coated, Extended Release | Oral | Boehringer Ingelheim Pharmaceuticals, Inc. | Human Prescription Drug |
